Atlantic Veterinary Internal Medicine & Oncology (AVIMO)
Study Purpose:
To better understand the molecular subtypes of canine lymphoma (B-cell and T-cell), improve treatment decisions, predict outcomes, and develop new therapies.
Study Overview:
• Dogs receive standard CHOP (or L-CHOP) chemotherapy for 25 weeks.
• Routine clinical staging and lymph node biopsy required.
• Blood and tissue samples collected for molecular analysis (genomic, transcriptomic, liquid biopsy).
• Side effects and treatment response monitored.
Client Incentives:
Study covers initial diagnostics.
$6,000 toward further treatment/diagnostics.
Inclusion Criteria
Dogs with intermediate to high-grade multicentric nodal lymphoma
Weight > 5kg
Peripheral lymph nodes ≥ 20 mm
Owner consent is required
Exclusion Criteria
Indolent lymphoma or lymphoma originating in non-lymphoid organs (e.g., eyes, kidneys, gastrointestinal tract) without involvement of peripheral lymph nodes.
Presence of significant systemic illness (e.g., severe kidney disease, liver failure, etc.).
Recent administration of anti-cancer medications (e.g., chemotherapy, corticosteroids) within the past 3 weeks.
